CS229934B2 - Production method subst.indolylacryte acid derivative - Google Patents

Production method subst.indolylacryte acid derivative Download PDF

Info

Publication number
CS229934B2
CS229934B2 CS825037A CS503782A CS229934B2 CS 229934 B2 CS229934 B2 CS 229934B2 CS 825037 A CS825037 A CS 825037A CS 503782 A CS503782 A CS 503782A CS 229934 B2 CS229934 B2 CS 229934B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
converted
pharmaceutically acceptable
compounds
Prior art date
Application number
CS825037A
Other languages
Czech (cs)
English (en)
Inventor
Peter E Cross
Roger P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS229934B2 publication Critical patent/CS229934B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS825037A 1981-07-07 1982-06-23 Production method subst.indolylacryte acid derivative CS229934B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8120878 1981-07-07
GB8213864 1982-05-13

Publications (1)

Publication Number Publication Date
CS229934B2 true CS229934B2 (en) 1984-07-16

Family

ID=26280039

Family Applications (1)

Application Number Title Priority Date Filing Date
CS825037A CS229934B2 (en) 1981-07-07 1982-06-23 Production method subst.indolylacryte acid derivative

Country Status (17)

Country Link
US (1) US4451472A (show.php)
EP (1) EP0069513B1 (show.php)
AR (1) AR230056A1 (show.php)
AU (1) AU532640B2 (show.php)
CS (1) CS229934B2 (show.php)
DD (1) DD202714A5 (show.php)
DE (1) DE3275545D1 (show.php)
DK (1) DK297382A (show.php)
ES (1) ES513765A0 (show.php)
FI (1) FI822386L (show.php)
GB (1) GB2101992A (show.php)
GR (1) GR76214B (show.php)
IL (1) IL66223A0 (show.php)
NO (1) NO822360L (show.php)
PL (1) PL240814A1 (show.php)
PT (1) PT75191B (show.php)
YU (1) YU145482A (show.php)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
CA2030557A1 (en) * 1989-03-31 1990-10-01 Hiroshi Matsui Imidazole derivatives, methods for their production and pharmaceutical use thereof
JPH03258779A (ja) * 1990-03-06 1991-11-19 Mitsui Toatsu Chem Inc イミダゾール誘導体及び該イミダゾール誘導体を有効成分とする抗痙攣剤
US5538973A (en) * 1992-03-27 1996-07-23 Kyoto Pharmaceutical Industries, Ltd. Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
GB9310635D0 (en) * 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
GB9319100D0 (en) * 1993-09-15 1993-11-03 Pfizer Ltd 3-(3-pyridinyl)h-indoles
JP6005740B2 (ja) 2011-07-29 2016-10-12 カリオファーム セラピューティクス,インコーポレイテッド ヒドラジド含有核輸送調節因子およびその使用
AU2013259384B2 (en) 2012-05-09 2016-06-02 Biogen Ma Inc. Nuclear transport modulators and uses thereof
EP2968278B8 (en) 2013-03-15 2019-05-22 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
WO2014205389A1 (en) 2013-06-21 2014-12-24 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
MX388170B (es) 2014-08-15 2025-03-19 Karyopharm Therapeutics Inc Polimorfos de selinexor
MA43529A (fr) 2015-12-31 2018-11-07 Karyopharm Therapeutics Inc Modulateurs de transport nucléaire et leurs utilisations
US10709706B2 (en) 2015-12-31 2020-07-14 Karopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
WO2018098472A1 (en) 2016-11-28 2018-05-31 Karyopharm Therapeutics Inc. Crm1 inhibitors for treating epilepsy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3445472A (en) * 1965-12-03 1969-05-20 American Home Prod Mono- and di-aroyl pyridylethyl and piperidylethyl indoles
FR2272081A1 (en) * 1974-05-22 1975-12-19 Labaz Anti-inflammatory indolylpyridylketones prepn. - from 2-alkyl (or aryl) indole and pyridine carboxylic acid chlorides
DE2960547D1 (en) * 1978-02-24 1981-11-05 Pfizer Ltd 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them
IT1162310B (it) * 1978-05-02 1987-03-25 Ono Pharmaceutical Co Derivati di imidazolo e procedimento per produrli
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
GB2045244B (en) * 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4363912A (en) * 1980-12-15 1982-12-14 Pfizer Inc. Indole thromboxane synthetase inhibitors

Also Published As

Publication number Publication date
AR230056A1 (es) 1984-02-29
DE3275545D1 (en) 1987-04-09
FI822386A0 (fi) 1982-07-05
ES8305355A1 (es) 1983-04-01
AU532640B2 (en) 1983-10-06
US4451472A (en) 1984-05-29
PT75191B (en) 1985-10-04
NO822360L (no) 1983-01-10
YU145482A (en) 1985-03-20
PL240814A1 (en) 1983-10-10
PT75191A (en) 1982-08-01
DK297382A (da) 1983-01-08
EP0069513B1 (en) 1987-03-04
GR76214B (show.php) 1984-08-04
GB2101992A (en) 1983-01-26
ES513765A0 (es) 1983-04-01
IL66223A0 (en) 1982-11-30
FI822386A7 (fi) 1983-01-08
DD202714A5 (de) 1983-09-28
EP0069513A3 (en) 1984-03-21
FI822386L (fi) 1983-01-08
AU8563882A (en) 1983-02-03
EP0069513A2 (en) 1983-01-12

Similar Documents

Publication Publication Date Title
EP0054417B1 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
US4273782A (en) Inhibition of thromboxane synthetase by 3-(1-Imidazolylalkyl) indoles
EP0003901B1 (en) 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them
US4448781A (en) N-Benzyl-imidazoles as selective inhibitors of the thromboxane synthetase enzyme
US4636500A (en) N-(phenoxyalkyl)imidazoles as selective inhibitors of the thromboxane synthetase enzyme and pharmaceutical compositions thereof
CS235023B2 (en) Method of thromboxan-synthetase's naphtalene and benzocyclic inhibitors' production
CS229934B2 (en) Production method subst.indolylacryte acid derivative
EP0035863B1 (en) Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
JP2007506772A (ja) Pai−1としてのヘテロサイクリックまたはアリールオキシ、−チオまたは−アミノ置換インドール−2−カルボン酸またはエステル
EP0029742A1 (en) Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4259345A (en) 2-(Imidazol-1-ylmethyl)pyrroles
US4230714A (en) Imidazole therapeutic agents
JPH04217955A (ja) 置換ベンズインドールイミン誘導体及びその製法
JPS5841875A (ja) インド−ルトロンボキサンシンセタ−ゼ抑制剤類、それらの製造法、およびそれらを含有する製薬的組成物
GB2118552A (en) Thromboxane synthetase inhibitors
GB2102795A (en) Indole derivatives
GB2101115A (en) Thromboxane synthetase inhibitors
JPS6022711B2 (ja) トランス−デカハイドロキノリン誘導体,その製造法,及びそれを含む医薬